Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22384
Title: | Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group |
Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
Keywords: | Adult,Aged,Antimetabolites, Antineoplastic/adverse effects/therapeutic use,Antineoplastic Agents, Phytogenic/adverse effects/therapeutic use,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Carcinoma, Small Cell/*drug therapy,Deoxycytidine/administration & dosage/adverse effects/*analogs &,derivatives/*therapeutic use,Female,Humans,Lung Neoplasms/*drug therapy,Male,Middle Aged,Taxoids/administration & dosage/adverse effects/*therapeutic use,Treatment Outcome |
URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/22384 |
ISSN: | 0169-5002 |
Link: | http://www.ncbi.nlm.nih.gov/pubmed/12826319 http://ac.els-cdn.com/S0169500203001545/1-s2.0-S0169500203001545-main.pdf?_tid=dbe5efcafe991384c9c5d31d0c9df963&acdnat=1333614043_ac24223447da3315e81b892ab58472cd |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Skarlos-2003-Docetaxel and gemcit.pdf | 159.58 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License